Medicine Use Preceding Fatal Poisonings Among Individuals With Bipolar Disorder
Basic & Clinical Pharmacology & Toxicology · 2026-10 · 139 (4)
DOI: 10.1111/bcpt.70305 ↗Kurz gefasst
Fachartikel in der Zeitschrift Basic & Clinical Pharmacology & Toxicology, online erschienen am 17.09.2026. Verfasst von Janina Salmelainen und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, University of Eastern Finland, Kuopio, Finland. Hauptthemen laut MEDLINE: Bipolar Disorder, Poisoning, Drug Overdose. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Pharmacotherapy may reduce overall suicide risk in bipolar disorder, but prescribed medicines can also be causative agents in suicidal and accidental poisonings. This nationwide, nested case–control study utilized data from several national registers in Finland in 1996–2018. In a cohort of 60 045 individuals aged 15–65 with bipolar disorder, cases with fatal poisoning due to medicines or illicit substances were matched by age and sex to four controls each. The association between fatal poisoning and medicine use in the prior 2 weeks was examined using conditional logistic regression. The 777 (1.3%) cases who died of poisoning due to medicines or illicit substances during the study period were matched to 3108 controls. Of cases, 56.5% ( n = 439) died of a suicidal poisoning and 38.4% ( n = 298) of an accidental poisoning. After adjusting for sociodemographic characters, comorbidities and other medicine use, tricyclic antidepressants (aOR 3.07, 95% CI 2.09–4.50), gabapentinoids (3.05, 2.08–4.47), opioids (2.65, 1.88–3.75), benzodiazepines (2.13, 1.71–2.64), Z‐drugs (2.19, 1.66–2.88) and antipsychotics (1.94, 1.56–2.40) were associated with fatal poisonings. While the associations may reflect clinical severity of the disorder among users of these medicines, increased caution is warranted when prescribing them to individuals at elevated risk of poisoning.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, University of Eastern Finland, Kuopio, Finland.
- Department of Forensic Psychiatry, University of Eastern Finland, Niuvanniemi Hospital, Kuopio, Finland.
- Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
- Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland.
- Center for Psychiatry Research, Stockholm Region, Stockholm, Sweden.
- Norwegian Centre for Addiction Research (SERAF), Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
ORCID-Profile: Janina Salmelainen, Miia Tiihonen, Heidi Taipale, Johannes Lieslehto, Antti Tanskanen, Jari Tiihonen, Aleksi Hamina
Zitieren
APA
Salmelainen, J., Tiihonen, M., Taipale, H., Lieslehto, J., Tanskanen, A., Tiihonen, J., & Hamina, A. (2026). Medicine Use Preceding Fatal Poisonings Among Individuals With Bipolar Disorder. Basic & Clinical Pharmacology & Toxicology, 139(4). https://doi.org/10.1111/bcpt.70305
Vancouver
Salmelainen J, Tiihonen M, Taipale H, Lieslehto J, Tanskanen A, Tiihonen J, et al. Medicine Use Preceding Fatal Poisonings Among Individuals With Bipolar Disorder. Basic & Clinical Pharmacology & Toxicology. 2026;139(4). doi:10.1111/bcpt.70305
BibTeX
@article{Salmelainen2026,
author = {Salmelainen, Janina and Tiihonen, Miia and Taipale, Heidi and Lieslehto, Johannes and Tanskanen, Antti and Tiihonen, Jari and Hamina, Aleksi},
title = {Medicine Use Preceding Fatal Poisonings Among Individuals With Bipolar Disorder},
journal = {Basic & Clinical Pharmacology & Toxicology},
year = {2026},
volume = {139},
number = {4},
doi = {10.1111/bcpt.70305}
}
EUVIMED